Influenza vaccination in autoimmune neuromuscular diseases: A survey of current practices and perceptions
Roy B, Litchman T, Torabi T, Nowak RJ. Influenza vaccination in autoimmune neuromuscular diseases: A survey of current practices and perceptions. Muscle & Nerve 2021, 63: 918-923. PMID: 33711167, DOI: 10.1002/mus.27224.Peer-Reviewed Original ResearchConceptsChronic inflammatory demyelinating polyneuropathyGuillain-Barré syndromeMyasthenia gravisInfluenza vaccinationInfluenza vaccineInflammatory demyelinating polyneuropathyAutoimmune neuromuscular diseaseAutoimmune neuromuscular disorderHistory of exacerbationsProfessional society recommendationsDemyelinating polyneuropathyGBS patientsVaccine recommendationsSociety recommendationsNeurology practitionersInternet-based surveyPatientsNeuromuscular diseaseUnmet needNeuromuscular disordersNeurologistsPractice settingsVaccinationVaccineRecommendation practicesGuillain-Barré Syndrome as a Complication of COVID-19
Zubair AS, Zubair AS, Desai K, Abulaban A, Roy B. Guillain-Barré Syndrome as a Complication of COVID-19. Cureus 2021, 13: e12695. PMID: 33614303, PMCID: PMC7883582, DOI: 10.7759/cureus.12695.Peer-Reviewed Case Reports and Technical NotesGuillain-Barre syndromeCases of GBSInitial COVID-19 infectionCOVID-19Multiple neurological complicationsIntravenous immunoglobulin therapyNerve conduction studiesCerebrospinal fluid analysisGuillain-Barré syndromeCOVID-19 infectionCoronavirus disease 2019Immunoglobulin therapyNeurological complicationsClinical suspicionSymptom onsetGBS casesIll patientsConduction studiesDisease 2019Correct diagnosisFluid analysisLonger durationComplicationsSyndromeInfection